Pharmalink AB Receives US Orphan Drug Designation for Nefecon(R) (PL-56) - PR Newswire (press release) Print
PR Newswire (press release)... which was designed to evaluate the efficacy and safety of Nefecon(R) in IgA nephropathy, a glomerulonephritis leading to end-stage renal disease (ESRD).

... read more